EP regimen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EP regimen, covering 2019-10-01 to 2019-10-01. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Sequential Anlotinib Followed by EP Regimen Plus Concurrent Radiotherapy for Unresectable Stage III Non-small Cell Lung Cancer [Phase 2]